Cutaneous T cell lymphoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)
Conditions: Lymphoma, T-cell, Peripheral; Lymphoma, T-cell, Cutaneous Intervention: Drug: Remitoro Sponsor: Eisai Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2021 Category: Research Source Type: clinical trials
